Avanos Medical AVNS Accounts Receivable, after Allowance for Credit Loss
Accounts Receivable, after Allowance for Credit Loss at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNet.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's accounts receivable, after allowance for credit loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's accounts receivable, after allowance for credit loss?
- Avanos Medical (AVNS) reported accounts receivable, after allowance for credit loss of $103M in Q1 2026.
- How has Avanos Medical's accounts receivable, after allowance for credit loss changed year-over-year?
- Avanos Medical's accounts receivable, after allowance for credit loss decreased by 1.7% year-over-year, from $104.8M to $103M.
- What is the long-term trend for Avanos Medical's accounts receivable, after allowance for credit loss?
- Over 5 years (2020 to 2025), Avanos Medical's accounts receivable, after allowance for credit loss has grown at a -0.9% compound annual growth rate (CAGR), from $108.6M to $103.8M.